Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV)
Clinical trial NCT04535999 · COMPLETED
Trial details
- NCT number
- NCT04535999
- Sponsor
- University of Pennsylvania
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-07
- Primary completion
- 2025-05-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.